Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
304.60    8.30 (2.80%)
Bid:
303.70
Ask:
303.90
Spread: 0.20 (0.066%)
Market Cap: £6.75b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

Directorate Changes

12 Mar 2021 09:00

RNS Number : 9998R
Sainsbury(J) PLC
12 March 2021
 

12 March 2021

J Sainsbury plc - Directorate Changes

Appointment of Adrian Hennah as Non-Executive Director and Chair of Audit Committee

J Sainsbury plc today announces that Adrian Hennah will join the Board as a Non-Executive Director. Adrian will join the Audit Committee and Nomination Committee on 1 April 2021 and will take over as Chair of the Audit Committee following the AGM.

Adrian will replace David Keens, who is not seeking re-election to the Board at the July 2021 AGM after six years of service.

Commenting on the appointment, Martin Scicluna, Chairman of Sainsbury's, said:

"I am delighted to welcome Adrian as a Non-Executive Director and Chair of the Audit Committee. As a highly accomplished CFO of three FTSE100 companies spanning 18 years, he has significant and varied expertise. Additionally, Adrian was a Non-Executive Director and Audit Committee Chair of another FTSE100 company for nine years and I am confident he will bring fresh thinking to our Board as we deliver against our plan.

"I would like to thank David Keens for his six years of service. He has been a thoughtful and influential voice on the Board and we are grateful for his significant contribution."

Adrian Hennah said:

"I am very pleased to be joining Sainsbury's and look forward to bringing my experience to the Board. I am familiar with the business through previous roles and have always been impressed by the company's values and commitment to do the right thing for its customers. It is an exciting time to be involved in food retail and I am looking forward to getting started."

Adrian spent 18 years in Chief Financial Officer (CFO) roles at three FTSE 100 companies. He was CFO at RB for seven years and held the same position at Smith & Nephew and Invensys. Prior to this he spent 18 years at GSK working in both finance and operations. Adrian began his career at PWC.

Adrian was previously Non-Executive Director and Chair of the Audit Committee at RELX. He stepped down from the Board last year having completed nine years of service. No further information is required to be disclosed under 9.6.13R of the UK Listing Rules.

 

Ends

Enquiries:

Investor Relations Media Relations

James Collins +44 (0) 20 7695 0080 Rebecca Reilly +44 (0) 20 7695 7295

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZFLFFFXLEBBF
Date   Source Headline
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSCommencement of Share Buyback Programme
17th Apr 20257:00 amRNSFinal Results
11th Apr 20252:00 pmRNSDirector/PDMR Shareholding
11th Apr 202510:00 amRNSHolding(s) in Company
7th Apr 202510:00 amRNSHolding(s) in Company
4th Apr 202511:00 amRNSHolding(s) in Company
3rd Apr 20257:00 amRNSDirectorate Change
1st Apr 20253:15 pmRNSTotal Voting Rights
31st Mar 202511:00 amRNSHolding(s) in Company
19th Mar 202511:00 amRNSHolding(s) in Company
14th Mar 20252:15 pmRNSDirector/PDMR Shareholding
13th Mar 202512:00 pmRNSHolding(s) in Company
6th Mar 202512:00 pmRNSAdditional Listing
3rd Mar 202511:20 amRNSTotal Voting Rights
3rd Mar 20257:05 amRNSSale of Argos Store Card Portfolio
14th Feb 202511:45 amRNSDirector/PDMR Shareholding
12th Feb 202511:00 amRNSDirector/PDMR Shareholding
3rd Feb 20253:30 pmRNSBlock listing Interim Review
3rd Feb 20253:15 pmRNSTotal Voting Rights
29th Jan 202511:40 amRNSPublication of Final Terms
17th Jan 20252:40 pmRNSDirector/PDMR Shareholding
17th Jan 202511:30 amRNSPublication of a Prospectus
10th Jan 20257:00 amRNSTrading Statement
8th Jan 202510:00 amRNSHolding(s) in Company
8th Jan 202510:00 amRNSHolding(s) in Company
2nd Jan 20251:10 pmRNSTotal Voting Rights
20th Dec 20241:00 pmRNSDirector/PDMR Shareholding
19th Dec 202410:30 amRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 202410:05 amRNSDirector Declaration
5th Dec 20247:00 amRNSTransaction in Own Shares
4th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 202411:40 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20243:15 pmRNSDirector/PDMR Shareholding
22nd Nov 20247:00 amRNSCommencement of Second Tranche of Share Buyback

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.